Results 231 to 240 of about 50,232 (267)
Some of the next articles are maybe not open access.

Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design.

Revista Española de Cardiología, 2019
INTRODUCTION AND OBJECTIVES Although clinical guidelines recommend invasive management in non-ST-segment elevation myocardial infarction (NSTEMI), this strategy is underused in frail elderly patients in the real world.
J. Sanchis   +31 more
semanticscholar   +1 more source

Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.

Atherosclerosis, 2019
BACKGROUND AND AIMS We compared the clinical impact of renin-angiotensin system inhibitors (RASI) on long-term clinical outcomes between ST-segment elevation (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) after successful ...
Y. H. Kim   +11 more
semanticscholar   +1 more source

Disimpaction induced NSTEMI

The American Journal of Emergency Medicine, 2021
Daniel L, Golden   +4 more
openaire   +2 more sources

Approach to STEMI and NSTEMI.

The Journal of the Association of Physicians of India, 2012
Acute coronary syndrome (ACS) refers to any constellation of clinical symptoms that are compatible with acute myocardial ischemia. ACS is divided into ST- elevated myocardial infarction (STEMI), non-ST elevated myocardial infarction (NSTEMI), and unstable angina (UA).
Lal C, Daga   +2 more
openaire   +1 more source

Systemic inflammation response index is associated MACE in patients with NSTEMI.

European Review for Medical and Pharmacological Sciences, 2023
M. O. Ozilhan   +7 more
semanticscholar   +1 more source

PCI in unstable angina and NSTEMI

2020
The incidence and mortality of non-ST-elevation myocardial infarction (NSTEMI) is high among all acute coronary syndromes. The NSTEMI, unlike ST-elevation myocardial infarction (STEMI) necessitates an invasive treatment, as thrombolytics are contraindicated.
Smit Shrivastava, Abhikrishna Singh
openaire   +1 more source

Increasing clarity for an early invasive strategy in NSTEMI

Catheterization and Cardiovascular Interventions, 2020
Key Points An early invasive strategy for NSTEMI resulted in lower MACE and recurrent ischemia compared with a delayed strategy. The significant risk of NSTEMI is affirmed, which warrants earlier and more directed invasive treatment. Future investigations need to confirm these findings in a randomized trial in high‐risk patients.
openaire   +2 more sources

Hepatotoxicity and Recurrent NSTEMI While on Pembrolizumab for Metastatic Giant Cell Bone Tumor

American Journal of the Medical Sciences, 2019
We present the first reported case showing metastatic giant bone cell tumor being treated successfully with pembrolizumab after failing prior tyrosine kinase inhibitor therapy.
J. Kwan, Renee Cheng, L. Feldman
semanticscholar   +1 more source

Timing of Invasive Coronary Angiography in NSTEMI

JACC: Cardiovascular Interventions, 2023
Jean-Philippe, Collet, Sripal, Bangalore
openaire   +2 more sources

Home - About - Disclaimer - Privacy